Hypoglycemic Agents: all 3,927 studies that test it
Page 10 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and ProgesteroneCompletedNCT01427595Not applicableResults posted
- A Study in Adults With Type 2 DiabetesCompletedNCT01421459Phase 3Results posted
- A Study in Adults With Type 1 DiabetesCompletedNCT01421147Phase 3Results posted
- Adipokines in Obese Adolescents With Insulin ResistanceCompletedNCT01410604Phase 4Results posted
- Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 DiabetesCompletedNCT01409239Phase 4Results posted
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCompletedNCT01408888Phase 1Results posted
- Topiramate for Alcohol Use in Posttraumatic Stress DisorderTerminatedNCT01408641Not applicableResults posted
- Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)CompletedNCT01405911Phase 2Results posted
- Pioglitazone for Heroin and for Nicotine DependenceTerminatedNCT01395797Phase 1/2Results posted
- Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of OxycodoneCompletedNCT01395784Phase 2Results posted
- Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean ParticipantsCompletedNCT01391663Phase 1Results posted
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
- Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesCompletedNCT01378117Phase 4Results posted
- Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes MellitusCompletedNCT01377844Phase 2Results posted
- Changes in Bone Turnover With Increased Incretin Hormone ExposureTerminatedNCT01374568Phase 4Results posted
- A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy SubjectsCompletedNCT01374178Phase 1Results posted
- Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing RegimensCompletedNCT01365507Phase 3Results posted
- Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-BrazilCompletedNCT01365091Phase 1Results posted
- Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic ShockCompletedNCT01352182Phase 1/2Results posted
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With ObesityTerminatedNCT01351753Phase 2Results posted
- Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung CancerTerminatedNCT01342770Phase 2Results posted
- Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 DiabetesCompletedNCT01342484Phase 2Results posted
- Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)CompletedNCT01340768Phase 3Results posted
- Exercise and Metformin in Colorectal and Breast Cancer SurvivorsCompletedNCT01340300Phase 2Results posted
- Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 DiabetesCompletedNCT01334229Phase 3Results posted
- Adjunctive Metformin Therapy in Double DiabetesCompletedNCT01334125Phase 3Results posted
- Long-term Study of KAD-1229 in Type 2 Diabetes PatientsCompletedNCT01333592Phase 3Results posted
- Carbohydrate Consumption as a Factor in Aspart DosingTerminatedNCT01333514Phase 4Results posted
- Prevention of Metabolic Complications of Glucocorticoid ExcessCompletedNCT01319994Phase 2/3Results posted
- Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318135Phase 2/3Results posted
- Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318122Phase 2/3Results posted
- Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318109Phase 2/3Results posted
- Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in JapanCompletedNCT01318083Phase 2/3Results posted
- Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318070Phase 2/3Results posted
- Metformin for the Treatment of Premature Pubarche in GirlsTerminatedNCT01316042Not applicableResults posted
- Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMICompletedNCT01312467Phase 2Results posted
- A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast CancerCompletedNCT01310231Phase 2Results posted
- Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer SurvivorsCompletedNCT01302379Not applicableResults posted
- Effect of Adipokines in Hemodialysis PatientsCompletedNCT01301027Not applicableResults posted
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCompletedNCT01300260Phase 1Results posted
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)CompletedNCT01296412Phase 3Results posted
- Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial LipidsCompletedNCT01293396Phase 4Results posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT01289639Not applicableResults posted
- Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesCompletedNCT01289119Phase 3Results posted
- Metformin Postpartum for GDM RCT for Reduced Weight RetentionCompletedNCT01280409Phase 4Results posted
- Pioglitazone in Early Parkinson's DiseaseCompletedNCT01280123Phase 2Results posted
- Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756CompletedNCT01278160Phase 4Results posted
- Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-componentsCompletedNCT01276327Phase 1Results posted
- Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell RecoveryCompletedNCT01272583Not applicableResults posted
- Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT01272193Phase 3Results posted
- Use of Exenatide and Pramlintide to Decrease Post-prandial HyperglycemiaCompletedNCT01269047Phase 4Results posted
- Glyburide Advantage in Malignant Edema and Stroke PilotCompletedNCT01268683Phase 1/2Results posted
- Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263509Phase 2/3Results posted
- Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedNCT01263496Phase 2Results posted
- Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263483Phase 2/3Results posted
- Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedNCT01263470Phase 2Results posted
- A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated TriglyceridesCompletedNCT01262638Phase 2Results posted
- Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity SurgeryCompletedNCT01257087Not applicableResults posted
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesCompletedNCT01243424Phase 3Results posted
- Metformin Versus Insulin in Gestational DiabetesCompletedNCT01240785Phase 4Results posted
- Satisfaction of Treatment Among Elderly Patients With Insulin TherapyCompletedNCT01240200Phase 4Results posted
- A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese SubjectsTerminatedNCT01235741Phase 2Results posted
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)CompletedNCT01234649Phase 3Results posted
- Cooperation of Insulin and GLP-1 on Myocardial Glucose UptakeCompletedNCT01232946Not applicableResults posted
- Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes MellitusCompletedNCT01226043Phase 4Results posted
- Effect of Pioglitazone on TIMP-3 and TACE in Type 2 DiabetesCompletedNCT01223196Phase 4Results posted
- Metformin to Reduce Heart Failure After Myocardial InfarctionCompletedNCT01217307Phase 2/3Results posted
- Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy VolunteersCompletedNCT01216397Phase 1Results posted
- Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
- Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs AloneCompletedNCT01215435Phase 4Results posted
- Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin TherapyCompletedNCT01215097Phase 3Results posted
- Metformin in Castration-Resistant Prostate CancerTerminatedNCT01215032Phase 2Results posted
- Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic ControlCompletedNCT01214239Phase 3Results posted
- Study of Glycemic Control on Liver Transplantation OutcomesCompletedNCT01211730Phase 4Results posted
- A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy ExistsCompletedNCT01209143Phase 1Results posted
- Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 DiabetesCompletedNCT01206322Phase 2Results posted
- Comprehensive Add on Study in JapanCompletedNCT01204294Phase 3Results posted
- Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the HospitalCompletedNCT01203774Phase 4Results posted
- Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and SulfonylureaCompletedNCT01195090Phase 4Results posted
- Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-studyCompletedNCT01194830Phase 3Results posted
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusCompletedNCT01194258Phase 2Results posted
- Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XRCompletedNCT01192152Phase 1Results posted
- Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)CompletedNCT01192139Phase 1Results posted
- Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset SeizuresCompletedNCT01191086Phase 3Results posted
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)CompletedNCT01189890Phase 3Results posted
- Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of FoodCompletedNCT01189201Phase 1Results posted
- Sitagliptin Therapy to Improve Outcomes After Islet AutotransplantCompletedNCT01186562Phase 4Results posted
- Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart TransplantationCompletedNCT01186250Phase 2Results posted
- Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip TherapyCompletedNCT01186003Not applicableResults posted
- A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or LymphomaTerminatedNCT01185548Phase 1Results posted
- Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced HyperglycemiaCompletedNCT01184014Phase 4Results posted
- START-J: SiTAgliptin in eldeRly Trial in JapanCompletedNCT01183104Not applicableResults posted
- 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 WeeksCompletedNCT01183013Phase 3Results posted
- New Treatment for Alcohol and Nicotine DependenceCompletedNCT01182766Phase 2/3Results posted
- Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedNCT01181674Phase 4Results posted
- Metformin for Weight Loss in SchizophreniaTerminatedNCT01177709Not applicableResults posted
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)CompletedNCT01177384Phase 3Results posted
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedNCT01165684Phase 4Results posted
- A Study of Postprandial Hyperglycemia in Participants With Type 2 DiabetesCompletedNCT01159938Phase 4Results posted
- Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With DiabetesCompletedNCT01156597Phase 3Results posted